Open access · CC-BY
via OpenAlex
Dysregulation of autophagy as a common mechanism in lysosomal storage diseases
Elena Seranova, Kyle J. Connolly, Malgorzata Zatyka, Tatiana Rosado Rosenstock, Timothy Geoffrey Barrett, Richard I. Tuxworth, Sovan Sarkar
Essays in Biochemistry · 2017 · ▲ 177 citations
Abstract
The lysosome plays a pivotal role between catabolic and anabolic processes as the nexus for signalling pathways responsive to a variety of factors, such as growth, nutrient availability, energetic status and cellular stressors. Lysosomes are also the terminal degradative organelles for autophagy(definition) through which macromolecules and damaged cellular components and organelles are degraded. Autophagy acts as a cellular homeostatic pathway that is essential for organismal physiology. Decline in autophagy during ageing or in many diseases, including late-onset forms of neurodegeneration is considered a major contributing factor to the pathology. Multiple lines of evidence indicate that impairment in autophagy is also a central mechanism underlying several lysosomal storage disorders (LSDs). LSDs are a class of rare, inherited disorders whose histopathological hallmark is the accumulation of undegraded materials in the lysosomes due to abnormal lysosomal function. Inefficient degradative capability of the lysosomes has negative impact on the flux through the autophagic pathway, and therefore dysregulated autophagy in LSDs is emerging as a relevant disease mechanism. Pathology in the LSDs is generally early-onset, severe and life-limiting but current therapies are limited or absent; recognizing common autophagy defects in the LSDs raises new possibilities for therapy. In this review, we describe the mechanisms by which LSDs occur, focusing on perturbations in the autophagy pathway and present the latest data supporting the development of novel therapeutic approaches related to the modulation of autophagy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1042/ebc20170055
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
Seranova, E., Connolly, K.J., Zatyka, M., Rosenstock, T.R., Barrett, T.G., Tuxworth, R.I., & Sarkar, S. (2017). Dysregulation of autophagy as a common mechanism in lysosomal storage diseases. <em>Essays in Biochemistry</em>. https://doi.org/10.1042/ebc20170055
Vancouver
Seranova E, Connolly KJ, Zatyka M, Rosenstock TR, Barrett TG, Tuxworth RI, et al. Dysregulation of autophagy as a common mechanism in lysosomal storage diseases. Essays in Biochemistry. 2017. doi:10.1042/ebc20170055.
BibTeX
@article{elena2017Dysreg,
title = {Dysregulation of autophagy as a common mechanism in lysosomal storage diseases},
author = {Elena Seranova and Kyle J. Connolly and Malgorzata Zatyka and Tatiana Rosado Rosenstock and Timothy Geoffrey Barrett and Richard I. Tuxworth and Sovan Sarkar},
journal = {Essays in Biochemistry},
year = {2017},
doi = {10.1042/ebc20170055},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Hematology & Oncology 2021
Open access · CC-BY
Role of lysosomes in physiological activities, diseases, and therapy
Frontiers in Cell and Developmental Biology 2017
Open access · CC-BY
Interorganelle Communication between Mitochondria and the Endolysosomal System
Neurochemical Research 2016
Open access · CC-BY
Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders
Medicinal Research Reviews 2024
Open access · CC-BY
Targeting lysosomal quality control as a therapeutic strategy against aging and diseases
Nature Reviews Drug Discovery 2012
Open access · CC-BY
Autophagy modulation as a potential therapeutic target for diverse diseases
PubMed Central 2018
Preprint · CC-BY